Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATRS | Common Stock | Award | $380K | +86K | +12.2% | $4.42 | 791K | Jun 10, 2021 | Direct | F1 |
transaction | ATRS | Common Stock | Tax liability | -$77.1K | -17.3K | -2.19% | $4.45 | 774K | Jun 13, 2021 | Direct | F2 |
transaction | ATRS | Common Stock | Tax liability | -$52.9K | -11.9K | -1.54% | $4.45 | 762K | Jun 13, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATRS | Stock Option (right to buy) | Award | $0 | +164K | $0.00 | 164K | Jun 10, 2021 | Common Stock | 164K | $4.42 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant. |
F2 | Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold. |
F3 | Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan. |
F4 | The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. |